Terms: = Liver cancer AND TAL1, TCL5, 6886, ENSG00000162367, SCL, P17542, tal-1 AND Treatment
6 results:
1. Exploring prognostic value and regulation network of PPP1R1A in hepatocellular carcinoma.
Wu X; Wang Y; Yang M; Wang Y; Wang X; Zhang L; Liao L; Li N; Mao M; Guan J; Ye F
Hum Cell; 2022 Nov; 35(6):1856-1868. PubMed ID: 36018458
[TBL] [Abstract] [Full Text] [Related]
2. Direct-acting antivirals for chronic hepatitis C.
Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012143. PubMed ID: 28922704
[TBL] [Abstract] [Full Text] [Related]
3. Direct-acting antivirals for chronic hepatitis C.
Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012143. PubMed ID: 28585310
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
Xiong H; Ni Z; He J; Jiang S; Li X; He J; Gong W; Zheng L; Chen S; Li B; Zhang N; Lyu X; Huang G; Chen B; Zhang Y; He F
Oncogene; 2017 Jun; 36(25):3528-3540. PubMed ID: 28166203
[TBL] [Abstract] [Full Text] [Related]
5. A novel cell cycle blocker extracted from Stellera chamaejasme L. inhibits the proliferation of hepatocarcinoma cells.
Kan XX; Li Q; Chen X; Wang YJ; Li YJ; Yang Q; Xiao HB; Wang ZX; Chen Y; Weng XG; Cai WY; Zhu XX
Oncol Rep; 2016 Jun; 35(6):3480-8. PubMed ID: 27109908
[TBL] [Abstract] [Full Text] [Related]
6. Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis.
Palmieri VO; Santovito D; Margari F; Lozupone M; Minerva F; Di Gennaro C; Todarello O; Palasciano G
Clin Exp Med; 2015 Feb; 15(1):65-72. PubMed ID: 24323278
[TBL] [Abstract] [Full Text] [Related]
